the vaccine – Page 102 – Communicable Diseases Research

Sex Disparities in Efficacy in COVID-19 Vaccines: A Systematic Review and Meta-Analysis

Article

Published on 2021-07-272022-10-28
Journal: Vaccines [Category] COVID-19,

Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa

인공 지능과 빅 데이터를 활용하여 아프리카의 COVID-19 임상 공중 보건 및 백신 출시 전략 최적화

Editorial

Published on 2021-07-262022-09-10
Journal: International Journal of Environmental Research an [Category] SARS, 변종,

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Article

Published on 2021-07-262022-10-04
Journal: Communications Biology [Category] SARS, 진단,

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Brief Communication

Published on 2021-07-262022-10-29
Journal: Nature Medicine [Category] COVID-19, Fulltext, SARS,

COVID-19 Vaccine Acceptance in a Sample From the United Arab Emirates General Adult Population: A Cross-Sectional Survey, 2020

Public Health

Published on 2021-07-262022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS,

[키워드] 95% CI acceptance age asked association COVID-19 COVID-19 pandemic COVID-19 situation COVID-19 vaccine cross-sectional survey develop Efficacy evaluate evaluated Factor Factors females Gender handling Healthcare system Immunity Influenza International Local Logistic regression analysis male outcome pandemic participant Public perception questionnaire receive receiving risk Sample SARS-CoV-2 Sharjah Side effects sociodemographic factors statistically significant Stress study population survey the disease the vaccine took place UAE United Arab Emirate vaccination Vaccine Vaccine acceptance Vaccine hesitancy was used
[DOI] 10.3389/fpubh.2021.614499 PMC 바로가기 [Article Type] Public Health

Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.

Public Health

Published on 2021-07-232022-10-31
Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS,

[키워드] approved AstraZeneca asymptotic baseline Community Compliance condition COVID-19 COVID-19 pandemic cumulative mortality eliminating expression Face mask Herd herd immunity Herd immunity threshold Human Immunity Impact Inc. increase in individual induce initial Intervention Isolation lockdowns mathematical moderate Moderna Novel coronavirus pandemic Pfizer positive proportion public health public health measure quarantine reduction in Reproduction number required resulting Safe significantly social-distancing stability The United States the vaccine Therapeutic benefit total population two subgroups vaccination Vaccine
[DOI] 10.3389/fpubh.2021.709369 PMC 바로가기 [Article Type] Public Health

Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics

입장 금지!SARS-COV-2 진입 억제제 : COVID-19 Therapeutics로서의 역할과 유용성

Review

Published on 2021-07-232022-09-01
Journal: Virology Journal [Category] SARS, 변종, 유전자 메커니즘, 진단,

[키워드] antibodies antigenic antigenic drift approval best COVID-19 COVID-19 pandemic COVID-19 therapeutics effective effective vaccine Emerging sarbecoviruses globe Health healthcare herd immunity highlight Immunity individual inhibitor Keep less life management mechanism of action Mild miniprotein Mortality Mutation Neutralizing antibodies neutralizing antibody new SARS-CoV-2 pandemic Population Prophylaxis recombinant ACE2 Sarbecoviruses SARS-CoV-2 SARS-CoV-2 entry SARS-CoV-2 variants significantly the vaccine Therapeutic strategies therapeutic strategy utility vaccinate Vaccine Vaccines variant Viral viral entry Viral entry inhibitors zoonotic sarbecoviruses
[DOI] 10.1186/s12985-021-01624-x PMC 바로가기 [Article Type] Review

Sociodemographic inequality in COVID-19 vaccination coverage among elderly adults in England: a national linked data study

Public Health

Published on 2021-07-232022-10-28
Journal: BMJ Open [Category] COVID-19, Fulltext, SARS,

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Article

Published on 2021-07-222022-10-04
Journal: The New England Journal of Medicine [Category] MERS, SARS, 진단, 치료기술,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome addition Administered Analysis attenuation BNT162b2 Breakthrough infection Care center circulation conditions conducted Control coronavirus coronavirus disease dose duration of illness effective Effectiveness febrile febrile symptom hazard ratio Health Infection Local Messenger RNA Moderna mRNA mRNA vaccine mRNA-1273 nasal swab participant Participants participants with SARS-CoV-2 Pfizer-BioNTech preventing infection prevention prospective cohort study Quantitative respiratory responders risk RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 testing sick Symptoms the mean the vaccine vaccination Vaccine viral RNA load were excluded
[DOI] 10.1056/NEJMoa2107058 PMC 바로가기 [Article Type] Article

Immune Assessment of BNT162b2 m-RNA-Spike Based Vaccine Response in Adults

Article

Published on 2021-07-222022-10-28
Journal: Biomedicines [Category] COVID-19,

[키워드] Activation anti-S anti-S2 antibody assessment B-specific response BNT162b2 vaccine CD134 CD25 Cell Cellular immune response circulation Clinical data doses ELISA expression flow cytometry follicular healthcare worker humoral IgG immune response immune system immunized Immunological response involved memory memory cell memory T mRNA-based of BNT162b2 peptide Peripheral blood response responses against SARS-CoV-2 SARS-CoV-2 vaccination second dose significant increases in subject subset T follicular helper cells T helper T-specific response the vaccine vaccination Vaccine vaccine efficacy Vaccines was tested were measured
[DOI] 10.3390/biomedicines9080868 PMC 바로가기 [Article Type] Article